Bausch Health Companies BHC Business Segments
| TTM Q1 '26 | TTM Q4 '25 | TTM Q3 '25 | TTM Q2 '25 | TTM Q1 '25 | ||
|---|---|---|---|---|---|---|
| Revenue by Business | ||||||
| Bausch + Lomb | $5.21B+2.1% | $5.1B+2.5% | $4.98B+1.7% | $4.89B+1.3% | $4.83B+0.8% | |
| Diversified | $917M-2.1% | $937M+3.0% | $910M-1.2% | $921M-3.4% | $953M+0.3% | |
| International | $1.16B+2.0% | $1.13B+2.4% | $1.11B-0.5% | $1.11B+0.2% | $1.11B-0.3% | |
| Salix | $2.68B+3.8% | $2.58B+2.3% | $2.52B+3.0% | $2.45B+2.9% | $2.38B+1.8% | |
| Solta Medical | $576M+11.2% | $518M-0.2% | $519M+5.7% | $491M+5.6% | $465M+5.7% | |
| Revenue by Product | ||||||
| Other revenues | $102M-7.3% | $110M-2.7% | $113M-3.4% | $117M+1.7% | $115M+7.5% | |
| Price Appreciation Credit | $18M0.0% | $18M-14.3% | $21M+5.0% | $20M0.0% | $20M+11.1% | |
| Product sales | $10.43B+2.7% | $10.16B+2.4% | $9.92B+1.8% | $9.74B+1.3% | $9.62B+1.0% |
Chart any of these lines over time, or line them up against competitors.
Compare these in charts →Questions, answered.
- How does Bausch Health Companies break its business down?
- Bausch Health Companies (BHC) reports revenue by business across 5 parts — Bausch + Lomb, Diversified, International, Salix and Solta Medical. Each is extracted from the segment footnotes and tracked over time.
- Where does Bausch Health Companies's segment data come from?
- Segment breakdowns are pulled from the segment footnotes in Bausch Health Companies's SEC filings (the XBRL dimensional tags), so every line ties back to a reported figure. Switch between quarterly, annual, and TTM, or open any segment for its full history.